CORINNE CONLEY: Open Payments
NPI 1457031817 · CLIVE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$769 in 45 payments from 11 companies in 2025. Trend: 2023 $303 · 2024 $1,357 · 2025 $769
Food & beverage: $769
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $188 |
| ABBVIE INC. | 12 | $157 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $81 |
| Phathom Pharmaceuticals, Inc. | 7 | $77 |
| Gilead Sciences, Inc. | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 3 | $50 |
| Ipsen Biopharmaceuticals, Inc | 2 | $49 |
| GENZYME CORPORATION | 1 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Celltrion USA Inc. | 1 | $26 |
Products named: TREMFYA, DUPIXENT, XIFAXAN, VOQUEZNA, CREON, RINVOQ, IQIRVO, ENTYVIO.
Industry payments across IA — which companies pay providers there.
